Avalo Therapeutics (NasdaqCM:AVTX) FY Conference Transcript

Avalo Therapeutics (NasdaqCM:AVTX) FY Conference March 03, 2026 09:50 AM ET Company ParticipantsGarry Neil - CEOConference Call ParticipantsStacy Ku - Biotechnology Equity Research AnalystStacy KuThanks so much for joining our 46th Annual Healthcare Conference. I'm Stacy Ku, part of the biotech team with my colleague, Vi Shah, and we're very happy to be hosting Avalo Therapeutics. With us today, we have Garry Neil, CEO, and in the crowd joining us is CFO, Chris Sullivan. Really thanks to everyone for coming ...